Apple can for now resume sales of its flagship smartwatches, after a U.S. appeals court on Wednesday paused a government commission’s import ban on the devices imposed in a patent dispute over its medical monitoring technology.
https://www.pharmalive.com/wp-content/uploads/2023/12/ReutersAppleWatch2.jpg12801920Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-12-27 17:43:182023-12-28 12:39:34Apple can temporarily sell smartwatches after U.S. appeals court win